CME Information

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nursing Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be reviewed in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/ certification board to determine course eligibility for your licensing/certification requirement.

Credit Designation Statement

American Medical Association (AMA) Credit Designation Statement – Enduring Content:

Amedco LLC designates the enduring material activity portion for a maximum of 32.25 (22.50 of recorded live hours plus 9.75 concurrent hours) AMA PRA Category 1 Credits™ for physicians.

Learners should claim only the credit commensurate with the extent of their participation in the activities. The 22.50 live hours cannot also be claimed as enduring hours.

American Board of Internal Medicine (ABIM) MOC Credit:

Hours for ABIM MOC credit are being reviewed. Please check our website for updated information at

Other Health Care Professionals:

Other health care professionals who participate in this CE activity may submit this statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.

Acknowledgment of Financial Commercial Support:

Fresenius Medical Care Renal Therapy Group, LLC and Relypsa.

Acknowledgment of In-Kind Commcercial Support:

No in-kind commercial support was received for this educational activity.

Track Descriptions & Learning Objectives

Pediatric Track

This annual pediatric nephrology course will build upon our experience of more than a decade long programs geared to improve the care of children with chronic or end-stage kidney disease. Our faculty are well-recognized members of this specialty who have conducted research in the areas of basic, clinical sciences and quality improvement. The carefully identified topics in this program represent timely, state of the art subjects that the audience will use to guide practice.



Pediatric Track Learning Objectives:

Upon the completion of this educational activity, learners should be able to:

  • Identify treatment guidelines of pediatric hypertension
  • Describe the dialysis management in special populations
  • Describe the impact of COVID-19 in the child
  • Describe the optimal communication with the caregivers of pediatric patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD)
  • Describe inherited and congenital conditions of the kidneys and urinary tract
  • Identify techniques to achieve optimal professional development and academic success

General Track

During the educational activities you will be able to asses current knowledge presented by world’s leading scientists who discuss the latest developments in kidney research, spanning from current findings of interest to the renal community, to basic science, clinical nephrology, acute and chronic kidney disease, hemodialysis and peritoneal dialysis management, kidney transplantation, and epidemiology.

Attending the educational activities will enhance your professional and personal development. It will allow you to integrate and relate clinical practice with research and innovation, which will lead you to improved patient outcomes and quality of life.


General Nephrology Track Learning Objectives:

Upon the completion of this educational activity, learners should be able to:

  • Describe the pathway of COVID-19 infection via ACE2 receptor and its therapeutic implications
  • Identify problems related to the impaired immune response in CKD / ESKD patients, including limited seroconversion following vaccination and increased susceptibility to infections.
  • Assess the lifelong legacy of childhood kidney diseases
  • Identify of most recent research on the use of extracorporeal therapies for patients with Alzheimer’s Disease
  • Appreciate the use of telemedicine and social media in the face of a pandemic
  • Assess the utility of patient-reported outcomes to improve patient care
  • Identify kidney patients with sleep-apnea and assess their risk and advice on treatment options

Nurse Care Team Track

The Nurse Care Track is designed by nurses for nurses. The program attracts nurse experts across the continuum of nephrology nursing and its purported with a mission to advance nephrology nursing practice, and positively influence outcomes in response to growing regulatory, safety and quality issues in nephrology.

The program promotes the professional and clinical role development of nephrology nurses through organized educational meetings that enhance learning, networking, and socialization for the purpose of improving CKD patient outcomes.


Nurse care Team Learning Objectives:

Upon the completion of this educational activity, learners should be able to:

  • IDescribe the impact of COVID-19 on quality and safety standards in the care of CKD patients and their families.
  • Identify key nursing care needs and discuss critical issues with dialysis patients and their families.
  • Describe key regulatory and compliance requirements in the care of CKD patients and their families.
  • Identify the learning needs of CKD care providers for home patients across the spectrum.